NCT06897137 Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology
| NCT ID | NCT06897137 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wake Forest University Health Sciences |
| Condition | Malignant Solid Neoplasm |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2026-04-26 |
| Primary Completion | 2028-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2026-04-26 with a primary completion date of 2028-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates how adolescent and young adults with cancer in the U.S. and their loved ones respond to questions that will later be used with people who may have cancer and other chronic health conditions
Eligibility Criteria
AYAs with a cancer history (AYA-C) Inclusion Criteria: * Young adults between the ages of 15 to 39 years; * First diagnosed with cancer during 15 to 39 years of age; * Able to read and understand English; * Live in the United States; * Have a new cancer diagnosis and are receiving curative treatment OR are currently 0 to 10 years post-treatment. Exclusion Criteria: * Diagnosed with basal cell skin cancer; or * Are currently receiving hospice care. AYAs General Population (AYA-GP) Inclusion Criteria: * Young adults between the ages of 15 to 39 years; * Able to read and understand English; and * Live in the United States. Caregivers of AYAs with cancer (AYA-Cg) Inclusion Criteria: * 18 years of age or older; * Able to read and understand English; * Live in the United States; * Have a child/ward/partner for whom they have provided care, AND * Their child/ward/partner is 15 to 25 years of age and meets the other eligibility criteria as an AYA participant with a cancer history (described above).
Contact & Investigator
John Salsman
PRINCIPAL INVESTIGATOR
Wake Forest Baptist Comprehensive Cancer Center
Frequently Asked Questions
Who can join the NCT06897137 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, studying Malignant Solid Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06897137 currently recruiting?
Yes, NCT06897137 is actively recruiting participants. Contact the research team at sbunch@wakehealth.edu for enrollment information.
Where is the NCT06897137 trial being conducted?
This trial is being conducted at Winston-Salem, United States.
Who is sponsoring the NCT06897137 clinical trial?
NCT06897137 is sponsored by Wake Forest University Health Sciences. The principal investigator is John Salsman at Wake Forest Baptist Comprehensive Cancer Center. The trial plans to enroll 3,000 participants.